Heparin before hospital for heart attack
Part of Heart & circulation clinical trials.
This trial tests whether giving a blood thinner (heparin) early, before you get to the hospital for a heart attack procedure, can improve outcomes. It is for people having a specific type of heart attack (STEMI) who will receive a balloon angioplasty within 2 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are having a type of heart attack called STEMI that started less than 12 hours ago
- Your doctor plans to do a balloon angioplasty (primary PCI) within 2 hours of your first medical contact
- You have not had any blood thinners (like heparin, warfarin, or similar) in the last 2 days
- You have not had a stroke, bleeding in the brain, or any major bleeding in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
This trial compares a drug-coated balloon to a drug-coated stent for opening blocked arteries during a heart attack. It aims to see which device works better for patients having a specific type of heart attack called STEMI.
This trial tests whether giving a clot-busting medication before transferring you to advanced heart attack treatment (PCI—a procedure that opens blocked arteries) is better than waiting. It's for patients having a specific type of heart attack (STEMI) when the advanced treatment center is far away.
This trial compares two blood-thinning medicines (bivalirudin vs. heparin) given during angioplasty to people who've already had a clot-buster for a heart attack. The goal is to see which one works better to keep arteries open without increasing bleeding risk.
This trial tests a balloon pump placed in a heart vein to help the heart recover after a severe heart attack. It is for people who have had an anterior STEMI and need emergency angioplasty.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Hear when a new Primary PCI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.